Is Eli Lilly and Company stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Eli Lilly and Company pays dividends. Last time was Tuesday 10th of December 2024 where the investors holding the stock on Friday 15th of November 2024 were paid CHF1.3 per share. Over the last 106 times between 1998 and 2024, Eli Lilly and Company has paid CHF56.89 with an average of CHF0.54 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Eli Lilly and Company 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was CHF113.00, you would have made a profit of CHF552.00 per share or 488.50%
No, the average daily trading liquidity for Eli Lilly and Company is CHF2 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Eli Lilly and Company has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.19, the company's ability to pay off the debt is normal. Eli Lilly and Company has a very good net profit margin of 20.48% and should have very high tolerances against inflation.
We have calculated the inflation risk for Eli Lilly and Company to be low [0.3 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.